| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 12/29/2004 | WO2004112793A1 Guanidino-substituted quinazolinone compounds as mc4-r agonists |
| 12/29/2004 | WO2004112719A2 Chemical compounds |
| 12/29/2004 | WO2004112709A2 Inhibitors of cathepsin s |
| 12/29/2004 | WO2004112704A2 Substituted piperidine compounds and methods of their use |
| 12/29/2004 | WO2004086050A3 Labelling agents for mass spectrometry comprising tertiary amines |
| 12/29/2004 | WO2004076412A3 Aminoheteroaryl compounds as protein kinase inhibitors |
| 12/29/2004 | WO2004066951A3 Quinoline derivatives as nk-2 and nk-3 receptor antagonists |
| 12/29/2004 | WO2003103671A8 Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 12/29/2004 | WO2003102097A8 The hydrochloride of (s)-(+)-3-[1-[2-(1-acetyl-2,3-dihydro-1h-indol-3-yl)ethyl]-1,2,3,6-tetrahydropyridin-4-yl]-6-chloro-1h-indole |
| 12/29/2004 | WO2003099793A8 1,2-azole derivatives with hypoglycemic and hypolipidemic activity |
| 12/29/2004 | EP1491541A1 Pyridazinone aldose reductase inhibitors |
| 12/29/2004 | EP1491540A1 Pyridazinone aldose reductase inhibitors |
| 12/29/2004 | EP1491539A1 1-n-aminobenzimidazole derivatives |
| 12/29/2004 | EP1491533A2 Quinoline-and naphthalenecarboxamides, pharmaceutical compositions thereof and their use as calpain inhibitors |
| 12/29/2004 | EP1491532A1 Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetyloholine receptors |
| 12/29/2004 | EP1491212A1 Remedy for sleep disturbance |
| 12/29/2004 | EP1490362A2 (homo)piperazine substituted quinolines for inhibiting the phosphorylation of kinases |
| 12/29/2004 | EP1490358A1 6-(4-substituted-anilino)pyrimidine derivatives, method for the preparation thereof and antiviral pharmaceutical composition comprising the same |
| 12/29/2004 | EP1490355A1 Indolylmaleimide derivatives |
| 12/29/2004 | EP1490353A1 Method for manufacture of sertindole |
| 12/29/2004 | EP1490352A1 Synthesis of piperidine and piperazine compounds as ccr5 antagonists |
| 12/29/2004 | EP1490344A2 Anxiolytic agents with reduced sedative and ataxic effects |
| 12/29/2004 | EP1490343A1 New aryl imidazoles and related compounds as c5a receptor modulators |
| 12/29/2004 | EP1490341A1 Novel adamantane derivatives |
| 12/29/2004 | EP1490340A1 Heteroaromatic urea derivatives as vr-1 receptor modulators for treating pain |
| 12/29/2004 | EP1490336A1 Piperidine or 8-aza-bicyclo(3.2.1)oct-3-yl derivatives useful as modulators of chemokine receptor activity (especially ccr5) |
| 12/29/2004 | EP1490334A1 Phthalimido derivatives as inhibitors of monoamine oxidase b |
| 12/29/2004 | EP1490067A2 Use of tyrosine kinase inhibitors for treating substance use disorders |
| 12/29/2004 | EP1490065A1 Benzylimidazolyl substituted 2-quinolinone and quinazolinone derivatives for use as farnesyl transferase inhibitors |
| 12/29/2004 | EP1490064A1 Substituted pyridinones as modulators of p38 map kinase |
| 12/29/2004 | EP1490062A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/29/2004 | EP1490056A1 N-'4-(2-imino-pyrrolidin-1-yl)phenyl)-acetamide and corresponding piperidine derivatives as factor xa inhibitors for the treatment of thrombo-embolic diseases |
| 12/29/2004 | EP1490054A2 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
| 12/29/2004 | EP1490043A2 Spirocyclic amides as cannabinoid receptor modulators |
| 12/29/2004 | EP1373259B1 Pyridazinone aldose reductase inhibitors |
| 12/29/2004 | EP1285917B1 Process for producing carbostyril derivative |
| 12/29/2004 | EP1282612B1 Alkynyl phenyl heteroaromatic glucokinase activators |
| 12/29/2004 | EP1257539B1 Amino pyrazole derivatives useful for the treatment of obesity and other disorders |
| 12/29/2004 | EP1233769A4 Novel compounds |
| 12/29/2004 | EP1230224B1 Substituted 5-benzyl-2,4-diaminopyrimidines |
| 12/29/2004 | EP1226138B1 Fab i inhibitors |
| 12/29/2004 | EP1226136B1 Tyrosine kinase inhibitors |
| 12/29/2004 | EP1216234B1 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 12/29/2004 | EP1177178B1 Heterocyclically substituted benzimidazoles, the production and application thereof |
| 12/29/2004 | EP1176140B1 Amide compounds and medicinal use thereof |
| 12/29/2004 | EP1123274B1 Substituted phenyl derivatives, their preparation and use |
| 12/29/2004 | EP1119551B1 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 12/29/2004 | EP1056729B1 N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl]guanidine derivatives for the treatment of ischemia |
| 12/29/2004 | EP0934303B1 Compounds useful for inhibition of farnesyl protein transferase |
| 12/29/2004 | EP0929545B1 Tricyclic inhibitors of farnesyl protein transferase |
| 12/29/2004 | CN1558934A Water-color ink |
| 12/29/2004 | CN1558933A Novel anthrapyridone compounds, water-base magenta ink compositions, and ink-jet recording process |
| 12/29/2004 | CN1558907A Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 12/29/2004 | CN1558904A Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same |
| 12/29/2004 | CN1558902A Insecticidal and acaricidal 3-substituted pyrazoles |
| 12/29/2004 | CN1558898A Antiviral agent |
| 12/29/2004 | CN1558897A Antidiabetic agents |
| 12/29/2004 | CN1558764A Substituted urea neuropeptide Y Y5 receptor antagonists |
| 12/29/2004 | CN1558761A Substituted benzimidazole compounds and their use for the treatment of cancer |
| 12/29/2004 | CN1558759A 病毒聚合酶抑制剂 Viral polymerase inhibitors |
| 12/29/2004 | CN1558758A Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 12/29/2004 | CN1558719A Nicotinic acid-heterocyclyl-amides and analogous pyrimidine derivatives serving as pesticides |
| 12/29/2004 | CN1557808A 3-substituted piperazine triadimenol antifungal compounds and their salts |
| 12/29/2004 | CN1182135C Method for producing heterocyclic compounds |
| 12/29/2004 | CN1182134C Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for treatment of pain |
| 12/29/2004 | CN1182123C Substituted bicyclic derivatives useful as anticancer agents |
| 12/29/2004 | CN1182114C Piperazine derivatives used as CCR5 antagonist |
| 12/29/2004 | CA2530461A1 6-arylamino-5-cyano-4-pyrimidinones as pde9a inhibitors |
| 12/29/2004 | CA2530058A1 Mucin synthesis inhibitors |
| 12/29/2004 | CA2529524A1 Substituted piperidine compounds and methods of their use |
| 12/29/2004 | CA2529250A1 Chinazoline derivatives as aurora kinase inhibitors |
| 12/29/2004 | CA2529161A1 Quinolyl amide derivatives as ccr-5 antagonists |
| 12/29/2004 | CA2529154A1 Novel compounds that modulate ppar.gamma. type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 12/29/2004 | CA2528538A1 Dual function compounds and uses thereof |
| 12/29/2004 | CA2524700A1 N-substituted 6,8-dialkoxy-1,2,3,4-tetrahydro-1h-isoquinoline as potassium channels modulators |
| 12/29/2004 | CA2523015A1 Guanidino-substituted quinazolinone compounds as mc4-r agonists |
| 12/28/2004 | US6835832 Catalytic hydrogenation |
| 12/28/2004 | US6835744 3,3-substituted indoline derivatives |
| 12/28/2004 | US6835741 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 12/28/2004 | US6835739 Benzamides and related inhibitors of factor Xa |
| 12/28/2004 | US6835737 Quinoline inhibitors of cGMP phosphodiesterase |
| 12/28/2004 | US6835731 Chemokine receptor binding heterocyclic compounds |
| 12/28/2004 | US6835728 Drug combination for the treatment of depression and related disorders comprising mirtazapine |
| 12/28/2004 | CA2281426C Substituted indole compounds as anti-inflammatory and analgesic agents |
| 12/28/2004 | CA2105923C 7-isoindolinyl-quinolone derivatives and 7-isoindolinyl-naphthyridone derivatives |
| 12/23/2004 | WO2004111193A2 Prodrugs of mitotic kinesin inhibitors |
| 12/23/2004 | WO2004111040A1 Heteroaryl-substituted imdazole derivatives as glutamate receptor antagonists |
| 12/23/2004 | WO2004111038A1 5,6-bis (4-chlorophenyl)-n-piperidin1-yl-3-(piperidin-1-yl-carbonyl)pyrazine-2-carboxamide |
| 12/23/2004 | WO2004111036A1 4- (heterocyclyl- fused phenyl)- 3- (phenyl or pyrid -2- yl) pyrazoles as inhibitors of the alk-5- receptor |
| 12/23/2004 | WO2004111035A1 Bicyclic indolyl derivatives and methods of their use as serotonergic agents |
| 12/23/2004 | WO2004111034A1 3-substituted 5,6-diaryl-pyrazine-2-carboxamide and -2-sulfonamide derivatives as cb1 modulators |
| 12/23/2004 | WO2004111033A1 2-substitued 5, 6-diaryl-pyrazine derivatives as cb1 modulator. |
| 12/23/2004 | WO2004111032A1 Substituted piperidine carbamates for use as inhibitors of hormone sensitive lipase |
| 12/23/2004 | WO2004111031A1 Pyridinyl carbamates as hormone-sensitive lipase inhibitors |
| 12/23/2004 | WO2004111030A1 Method for preparing fused oxazinones |
| 12/23/2004 | WO2004111029A2 Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole |
| 12/23/2004 | WO2004111014A1 Pyrimidine derivatives as modulators of atp-binding cassette transporters |
| 12/23/2004 | WO2004111013A1 Hepatitis c virus inhibitors |
| 12/23/2004 | WO2004111009A1 Fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 12/23/2004 | WO2004111007A1 1-aryl-4-(aryloxycarbonyl)-piperazine derivatives for use as inhibitors of hormone sensitive lipase |